Back to Search
Start Over
Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus
- Source :
- Archives of Endocrinology and Metabolism, Vol 66, Iss 6, Pp 868-870 (2022)
- Publication Year :
- 2022
- Publisher :
- Brazilian Society of Endocrinology and Metabolism, 2022.
-
Abstract
- “What's in a name? That which we call a rose / By any other name would smell as sweet” (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare's implication is that a name is nothing but a word and it therefore represents a convention with no intrinsic meaning. Whilst this may be relevant to romantic literature, disease names do have real meanings, and consequences, in medicine. Hence, there must be a very good rational for changing the name of a disease that has a centuries-old historical context. A working group of representatives from national and international endocrinology and endocrine pediatric societies now proposes changing the name of “diabetes insipidus” to “Arginine Vasopressin Deficiency (AVP-D)” for central etiologies, and “Arginine Vasopressin Resistance (AVP-R)” for nephrogenic etiologies This editorial provides both the historical context and the rational for this proposed name change.
- Subjects :
- Medicine
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Subjects
Details
- Language :
- English
- ISSN :
- 23594292 and 23593997
- Volume :
- 66
- Issue :
- 6
- Database :
- Directory of Open Access Journals
- Journal :
- Archives of Endocrinology and Metabolism
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.233da044b41aa8f9d7efab38b4a01
- Document Type :
- article
- Full Text :
- https://doi.org/10.20945/2359-3997000000528